Chandan Healthcare Shares Jump Nearly 5% Following Preferential Issue and Nationwide Partnership Expansion

Lucknow, October 10, 2025: Chandan Healthcare Limited (NSE: CHANDAN) shares surged nearly 5% in today’s trading session. The rally followed key strategic announcements, including an increase in authorised share capital, a preferential issue of equity warrants, and a new nationwide diagnostic partnership.

Headquartered in Lucknow, Chandan Healthcare Limited is an NSE SME Emerge-listed company providing diagnostic testing and healthcare facility operations. Since its listing in February 2025, the company has been focused on expanding its diagnostic and medical services footprint across India.

Board Approvals and Capital Expansion

In today’s board meeting, Chandan Healthcare Limited approved several measures aimed at strengthening its capital structure and supporting growth. The company raised its authorised share capital from ₹25 crore to ₹30 crore, divided into 3 crore equity shares of ₹10 each. The board also approved a preferential issue of up to 44.5 lakh fully convertible equity warrants, with each warrant convertible into one equity share.

Key participants in the issuance include NEGEN Undiscovered Value Fund, NEGEN Capital Services Pvt. Ltd., and Jeena Sikho Lifecare Ltd., among a total of 18 investors. Following the allotment, promoter holdings are expected to decrease from 49.47% to 43.23%, while public shareholding will rise to 56.77%.

Strategic Diagnostic Partnership

Chandan Healthcare has entered into an exclusive partnership with Jeena Sikho Lifecare Ltd, making the company the sole diagnostic provider across all existing and upcoming Jeena Sikho hospitals and clinics. This collaboration is expected to significantly expand Chandan’s presence in healthcare diagnostics nationwide.

Market Snapshot

As of 02:04 pm IST, the stock was trading at ₹288, up 4.99% from its previous close. Trading volume stood at 1.55 lakh shares, with a VWAP of ₹286.87, reflecting active investor interest. The company’s market capitalization currently stands at ₹704.22 crore, and the 52-week high has been set at ₹288, marking a fresh peak for the counter.

REF: https://nsearchives.nseindia.com/corporate/CHANDAN_10102025102045_Outcome_BM_10-10-2025.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations